| CLL BCR set | Identical VH/VK BCR | TC+ | TC+ CD40–/– | ≤2 mo B1 B cell origin | |
|---|---|---|---|---|---|
| IgH | IgL | ||||
| VH genea | Vk geneb | n = 155 | n = 18 | n = 20 | |
| 1 | VH12-1 (V261) | Vk4-91 (kf4) | 40 (25.8 %) | 4 (22.2%) | 4 |
| 2 | J558-64 (V332) | Vk12-89 (fl12) | 19 (12.3 %) | 3 (16.6%) | 2 |
| 3 | Q52-1 (V222) | Vk9-96 (ce9) | 14 (9.0 %) | 1 (5.6%) | 2 |
| 4 | J558-67 (V328) | Vk1-117 (cr1) | 10 (6.5 %) | 1 (5.6%) | 3 |
| 5 | VH11-2 (V235) | Vk9-128 (br9) | 4 (2.6 %) | 1 (5.6%) | nd |
| CLL BCR set | Identical VH/VK BCR | TC+ | TC+ CD40–/– | ≤2 mo B1 B cell origin | |
|---|---|---|---|---|---|
| IgH | IgL | ||||
| VH gene | Vk gene | ||||
| 1 | VH12-1 (V261) | Vk4-91 (kf4) | 40 (25.8 %) | 4 (22.2%) | 4 |
| 2 | J558-64 (V332) | Vk12-89 (fl12) | 19 (12.3 %) | 3 (16.6%) | 2 |
| 3 | Q52-1 (V222) | Vk9-96 (ce9) | 14 (9.0 %) | 1 (5.6%) | 2 |
| 4 | J558-67 (V328) | Vk1-117 (cr1) | 10 (6.5 %) | 1 (5.6%) | 3 |
| 5 | VH11-2 (V235) | Vk9-128 (br9) | 4 (2.6 %) | 1 (5.6%) | nd |
Presence of CLL stereotyped BCRs in TCL1+(TC+) CLL samples expressing identical VH and VL combination, including CD40 deficiency, and CLL developed by IgM+ B1 B cell transfer from TC+ neonatal/young mice (≤2 mo old). n, total sample number. nd, not detected.
VH gene (see Table S1 and Vbase2 for parentheses).
Vk gene (Thiebe et al., 1999).
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.